Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Laura Morgan
Authored Items
Challenges and Opportunities in Managing Type 2 Diabetes
Laura Morgan
June 2017 Vol 10, No 4
in
Conference Highlights AMCP
Defitelio (Defibrotide Sodium): First Drug Approved for Patients with Hepatic Veno-Occlusive Disease
Laura Morgan
March 2017, Vol 10, Eighth Annual Payers' Guide
in
Select Drug Profiles
,
Payers' Guide
US Healthcare Annual Spending Estimated to Rise by 5.8% on Average Through 2024
Laura Morgan
July/August 2015 Vol 8 No 5
in
Industry Trends
Adherence to Ibrutinib Therapy Improves Outcomes in Patients with CLL
Laura Morgan
August 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
in
Leukemia
The Impact of Rosacea and Acne on a Patient’s Quality of Life Is Comparable to Other Chronic Conditions
Laura Morgan
Payer Perspectives in Dermatology
Last modified: January 9, 2015
